DSM B.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
17 feb 2011 - 18:23
Statutaire naam
DSM B.V.
Titel
DSM Announces Receipt of Final Competition Clearance for Acquisition of Martek
Bericht
Royal DSM N.V. (NYSE Euronext: DSM KON), the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announces today that it has received the unconditional clearance of the Counsel of the National Competition Commission in Spain for its previously announced tender offer for all outstanding shares of common stock of Martek Biosciences Corporation (NASDAQ: MATK) at a price of $31.50 per share (the "Offer"). This was the final clearance needed under applicable antitrust and competition laws and this condition of the Offer is thus completely satisfied.
Gerelateerde downloads
Datum laatste update: 19 december 2025